Skip to main content

Daiichi Sankyo Value Stock - Dividend - Research Selection

Daiichi Sankyo Co Ltd

ISIN: JP3475350009, WKN: A0F57T

Market price date: 08.01.2021
Market price: 3.645,00 JPY




Daiichi Sankyo Co Ltd Fundamental data and company key figures of the share

Annual reports in JPY
Key figures 03-05-2020
Cash flow
Net operating cash flow 196.601.000.000
Capital Expenditures -52.565.000.000
Free cash flow 144.036.003.840
Balance sheet
Total Equity 1.306.270.000.000
Liabilities & Shareholders equity 2.105.620.000.000
Income statement
Net income 129.074.000.000
Eps (diluted) 66,000
Diluted shares outstanding 1.955.670.000
Net sales/revenue 981.793.000.000

Fundamental ratios calculated on: 08-01-2021

Ratios
Key figures 08-01-2021
Cash flow
P/C 0,00
   
P/FC 0,00
Balance sheet
ROI6,13
ROE62,04
Income statement
P/E55,23
Div. Yield0,00%
P/B0,00
P/S7,26


Do you want to do make a detailed fundamental analysis of this stock?

✓ NEW Fundamental API Access to 500 data points per month
Fundamental data up to 25 years
Comparison to all other stocks by the FScore
Time saving!

How our site works ...

Non-binding 7 days without automatic subscription
 No termination required after the free week
Finanzoo fundamental analysis
Data updated daily
Virtual depots
Share alarms via email
Subscription can be canceled at any time at the end of the month 
Choice of desired shares
Over 2000 stock analyzes available
Bitcoin payment possible if you do not want to subscribe

Price for monthly subscription $ 19.99 / month including VAT.



DescriptionData
Symbol4568.TSE
Market Capitalization68.726.185.984,00 USD
CountryJapan
IndicesNIKKEI 225
SectorsPharma
Raw Data SourceIFRS in Millionen JPY
Stock Split2020-09-29,3.000000/1.000000
Internetwww.daiichisankyo.co.jp


Description of the company

DAIICHI SANKYO COMPANY, LIMITED is a Japan-based holding company, mainly engaged in the manufacture and distribution of pharmaceuticals. The company is engaged in the research, development, manufacture and sale of pharmaceuticals, as well as the supply of intermediates and bases for pharmaceutical production in Japan, the US, Europe, China and Brazil. As of March 31, 2014, the Company had more than 100 subsidiaries and four associates.

The Finanzoo GmbH assumes no liability for the accuracy of the information! All information is provided without warranty. Sources:: www.bundesanzeiger.de, www.sec.gov, www.daiichisankyo.co.jp